Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
H U Group HoldingsMRCHF 63 Return-on-Tangible-Asset is 2.11% as of Mar. 2026, which is 3% above its 10-year median of 2.05. GuruFocus rates MRCHF with a GF Score™ of 63/100 and a GF Value™ of $19.10 (Fairly Valued). The stock has 5 warning signs investors should review. Among 212 Medical Diagnostics & Research companies, H U Group Holdings ranks better than 65.09% on this metric.
Return-on-Tangible-Asset is calculated as Net Income divided by its average total tangible assets. Total tangible assets equals to Total Assets minus Intangible Assets. H U Group Holdings's annualizedNet Income for the quarter that ended in Mar. 2026 was $31 Mil. H U Group Holdings's average total tangible assets for the quarter that ended in Mar. 2026 was $1,459 Mil. Therefore, H U Group Holdings's annualized Return-on-Tangible-Asset for the quarter that ended in Mar. 2026 was 2.11%.
The historical rank and industry rank for H U Group Holdings's Return-on-Tangible-Asset or its related term are showing as below:
MRCHF'
s Return-on-Tangible-Asset Range Over the Past 10 Years
Min: -3.04 Med: 2.05 Max: 12.4
Current: 2.96
During the past 13 years, H U Group Holdings's highest Return-on-Tangible-Asset was 12.40%. The lowest was -3.04%. And the median was 2.05%.
MRCHF's Return-on-Tangible-Asset is ranked better than 65.09% of 212
companies
in the Medical Diagnostics & Research industry
Industry Median: -2.325
vs MRCHF: 2.96
H U Group Holdings (OTCPK:MRCHF) Return-on-Tangible-Asset Explanation
Return-on-Tangible-Asset measures the rate of return on the average total tangible assets (total assets minus intangible assets). Tangible means physical in nature. Intangible Assets are assets that are not physical in nature, and typically "derive their value from legal or intellectual rights." Return-on-Tangible-Asset measures a firm's efficiency at generating profits from its tangible assets. It shows how well a company uses what it has to generate earnings. Return-on-Tangible-Assets can vary drastically across industries. Therefore, Return-on-Tangible-Asset should not be used to compare companies in different industries.
Be Aware
Like ROE and ROA, Return-on-Tangible-Asset is calculated with only 12 months data. Fluctuations in the companys earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. Return-on-Tangible-Asset can be affected by events such as stock buyback or issuance, and by a companys tax rate and its interest payment. Return-on-Tangible-Asset may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high Return-on-Tangible-Asset may indicate vulnerability in the durability of the competitive advantage.
H U Group Holdings Return-on-Tangible-Asset Related Terms
H U Group Holdings Return-on-Tangible-Asset Historical Data
* Premium members only.
The historical data trend for H U Group Holdings's Return-on-Tangible-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MRCHF vs TMO, DHR, IDXX: Return-on-Tangible-Asset Comparison
For the Diagnostics & Research subindustry, H U Group Holdings's Return-on-Tangible-Asset, along with its competitors' market caps and Return-on-Tangible-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
H U Group Holdings Return-on-Tangible-Asset vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, H U Group Holdings's Return-on-Tangible-Asset distribution charts can be found below:
* The bar in red indicates where H U Group Holdings's Return-on-Tangible-Asset falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Asset, the net income of the last fiscal year and the average total tangible assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is four times the quarterly (Mar. 2026) net income data.
What does a Return-on-Tangible-Asset of 2.11% mean?
H U Group Holdings (MRCHF) has a Return-on-Tangible-Asset of 2.11% as of Mar. 2026. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on H U Group Holdings and its competitors. This is near median its historical median of 2.05. According to the industry distribution chart, H U Group Holdings ranks #74 out of 212 companies in the Medical Diagnostics & Research industry, placing it in the top 34.9%.
Is H U Group Holdings' Return-on-Tangible-Asset too high?
H U Group Holdings' current Return-on-Tangible-Asset of 2.11% is near median its 10-year median of 2.05. Based on the distribution chart, H U Group Holdings ranks #74 out of 212 companies in the Medical Diagnostics & Research industry, which is above the industry midpoint. Overall, H U Group Holdings has a GF Score™ of 63/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does H U Group Holdings' Return-on-Tangible-Asset compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, H U Group Holdings ranks #74 out of 212 companies for Return-on-Tangible-Asset. This puts H U Group Holdings in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Asset for a Medical Diagnostics & Research company?
A good Return-on-Tangible-Asset depends on the Medical Diagnostics & Research industry context. However, Return-on-Tangible-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Asset mean?
A high Return-on-Tangible-Asset can signal that a stock is expensive relative to its fundamentals. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on H U Group Holdings and its competitors. H U Group Holdings's current Return-on-Tangible-Asset is 2.11%, which is near median its own 10-year median of 2.05. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is H U Group Holdings stock overvalued right now?
Based on GuruFocus' analysis, H U Group Holdings (MRCHF) is currently considered Fairly Valued. The stock's GF Value™ is $19.10, compared to a current price of $19.70 — trading 3.1% above its estimated fair value. The current Return-on-Tangible-Asset is 2.11%, which is near median its 10-year median of 2.05. H U Group Holdings' overall GF Score™ is 63/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Asset calculated?
Return-on-Tangible-Asset is calculated from a company's financial statements. For H U Group Holdings (MRCHF), the current Return-on-Tangible-Asset is 2.11% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is H U Group Holdings (MRCHF) Overvalued in 2026?
Based on GuruFocus' analysis, H U Group Holdings stock appears to be overvalued.
The current stock price of $19.70 is trading 3.1% above its estimated GF Value™ of $19.10.
GuruFocus considers H U Group Holdings to be Fairly Valued.
Key valuation signals for MRCHF:
Return-on-Tangible-Asset: 2.11% (near median its 10-year median of 2.05)
GF Value™: $19.10 vs. price of $19.70 (3.1% above fair value)
No single metric tells the full story. See the MRCHF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
H U Group Holdings Inc operates in the healthcare field, focusing on clinical laboratory testing and reagents. The company is engaged in four main businesses. The Clinical Laboratory Testing Business receives samples taken from patients at medical institutions to test for the disease and confirm the condition of the patient's health; In Vitro Diagnostics develops, manufactures, and sells testing reagents and equipment inside and outside Japan; Sterilization & Related Services Business provides a range of medical-related services including sterilization; and Emerging New Business & Others is a new business for future growth.
63GF Score
Get the complete analysis for MRCHF
Return-on-Tangible-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MRCHF has been successfully added to your 
